Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021

SELL
$5.03 - $8.8 $411,957 - $720,720
-81,900 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$3.64 - $7.76 $24,024 - $51,216
6,600 Added 8.76%
81,900 $345,000
Q2 2020

Aug 14, 2020

SELL
$4.78 - $8.26 $857,532 - $1.48 Million
-179,400 Reduced 70.44%
75,300 $521,000
Q1 2020

May 15, 2020

BUY
$4.0 - $21.53 $813,600 - $4.38 Million
203,400 Added 396.49%
254,700 $1.02 Million
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $715,122 - $1.24 Million
51,300 New
51,300 $1.1 Million
Q1 2019

May 15, 2019

SELL
$12.61 - $22.33 $616,629 - $1.09 Million
-48,900 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$12.41 - $22.98 $39,712 - $73,536
-3,200 Reduced 6.14%
48,900 $665,000
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $54,145 - $359,567
22,100 Added 73.67%
52,100 $848,000
Q2 2018

Aug 14, 2018

BUY
$2.68 - $3.48 $80,400 - $104,400
30,000 New
30,000 $93,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $238M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.